'''Table 1 - Clinically significant copy number alterations in breast cancer'''
+
'''Table 1 - Clinically significant copy number alterations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics.
{| class="wikitable"
{| class="wikitable"
|'''Alteration'''
|'''Alteration'''
Line 71:
Line 71:
|METABRIC IntClust1, ER Positive
|METABRIC IntClust1, ER Positive
|}
|}
−
'''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer'''
+
'''Table 2 - Major clinically significant genes associated with somatic sequence alterations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics.
{| class="wikitable"
{| class="wikitable"
|'''Gene(s)'''
|'''Gene(s)'''
Line 253:
Line 253:
|Benign or likely benign
|Benign or likely benign
|}
|}
−
'''Table 3 - Genes with known hereditary risk associations in breast cancer'''
+
'''Table 3 - Genes with known hereditary risk associations in breast cancer''' Table derived from Geiersbach et al., 2018 [<nowiki>PMID 32087595</nowiki>] with permission from Cancer Genetics.